{"id":32430,"date":"2026-02-09T05:36:14","date_gmt":"2026-02-09T05:36:14","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/cancer-vaccines-market-mordor\/"},"modified":"2026-09-11T06:15:28","modified_gmt":"2026-09-10T21:15:28","slug":"cancer-vaccines-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/cancer-vaccines-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc554 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026\ub144 &#8211; 2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cancer-vaccines-market_1667194898388_cancer_vaccines-_MP.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cancer-vaccines-market-size-image-1768931145232.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \uc5f0\uad6c \ubc94\uc704<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \uc2dc\uc7a5 \uac1c\uc694<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \uc2dc\uc7a5 \ub3d9\uc778<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \uc804 \uc138\uacc4 \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 R&amp;D \ud22c\uc790 \ubc0f \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 \uc99d\uac00<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 mRNA \ubc0f \uc2e0\uc0dd\ud56d\uc6d0 \ud50c\ub7ab\ud3fc\uc758 \ubc1c\uc804<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 AI \uae30\ubc18 \ud56d\uc6d0 \uc608\uce21\uc73c\ub85c \ube44\uc6a9 \uc808\uac10<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \ud5c8\ube0c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 CPI\uc640\uc758 \ubcd1\uc6a9 \uc694\ubc95\uc73c\ub85c \uc784\uc0c1 \uc2dc\ud5d8 \uc704\ud5d8 \uac10\uc18c (\uacfc\uc18c \ubcf4\uace0\ub428)<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \uc2dc\uc7a5 \uc81c\uc57d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \uc5c4\uaca9\ud55c \uaddc\uc81c \uc77c\uc815 \ubc0f \ubcf5\uc7a1\uc131<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \ub300\uccb4 \uba74\uc5ed \uc694\ubc95\uc758 \uac00\uc6a9\uc131<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 \ub9de\ucda4\ud615 \ubb3c\ub958\ub97c \uc704\ud55c \ucf5c\ub4dc\uccb4\uc778 \uaca9\ucc28<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \uc2e0\uc0dd\ud56d\uc6d0 IP \ud074\ub7ec\uc2a4\ud130\ub9c1\uc73c\ub85c \uc9c4\uc785 \uc81c\ud55c<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \uaddc\uc81c \ud658\uacbd<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \uae30\uc220 \uc804\ub9dd<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.6.1 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.6.2 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.6.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \uae30\uc220\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \uc7ac\uc870\ud569 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f DNA \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 mRNA\/\uc2e0\ud56d\uc6d0 \ub9de\ucda4\ud615 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \uc804\uc138\ud3ec \ubc0f \uc218\uc9c0\uc0c1\uc138\ud3ec \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 \uae30\ud0c0 \uae30\uc220<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \uce58\ub8cc \ubc29\ubc95\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \uc608\ubc29 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \uce58\ub8cc \ubc31\uc2e0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \uc554 \uc720\ud615\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \uc790\uad81\uacbd\ubd80\uc554 (HPV)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \uc804\ub9bd\uc120\uc554<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \ud751\uc0c9\uc885<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.4 \uae30\ud0c0 \uc554<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \ud22c\uc5ec \uacbd\ub85c\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \uadfc\uc721 \ub0b4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \ud53c\ub0b4 \/ \ud53c\ud558<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \uc815\ub9e5 \ub0b4<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \uc9c0\uc5ed\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \ubd81\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \ubbf8\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \uce90\ub098\ub2e4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \uba55\uc2dc\ucf54<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \uc720\ub7fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \ub3c5\uc77c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \uc601\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \ud504\ub791\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \uc2a4\ud398\uc778<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \ub7ec\uc2dc\uc544<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.7 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \uc911\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \uc77c\ubcf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \uc778\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \ud638\uc8fc<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \ub0a8\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \ube0c\ub77c\uc9c8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.3.1 Merck &amp; Co., Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.2 GlaxoSmithKline plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.3 Moderna Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.4 Bristol Myers Squibb Co.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.5 AstraZeneca plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.6 F. Hoffmann-La Roche AG (Genentech)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.7 BioNTech SE<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.8 Gritstone bio, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.9 Vaccitech plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.10 OSE Immunotherapeutics SA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.11 Anixa Biosciences Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.12 Dendreon Pharmaceuticals LLC<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.13 Providence Therapeutics Holdings<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.14 eTheRNA Immunotherapies NV<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.15 Imugene Ltd.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.16 Transgene SA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.17 OncoSec Medical Incorporated<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.18 NantKwest Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.19 Ultimovacs ASA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.20 ISA Pharmaceuticals BV<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc554 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \ub3d9\ud5a5 \ubd84\uc11d (2026-2031)<\/p>\n<p>\uc554 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 2025\ub144 106.7\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 117.5\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 190.6\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 10.14%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uac00\uc18d\ud654\ub41c \uc131\uc7a5\uc740 \uae30\uc874\uc758 \uc608\ubc29\uc801 \uc811\uadfc \ubc29\uc2dd\uc5d0\uc11c \ud658\uc790 \ub9de\ucda4\ud615 mRNA \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc\uc81c\ub85c\uc758 \uc804\ud658\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc778\uacf5\uc9c0\ub2a5(AI) \uae30\ubc18 \ud56d\uc6d0 \uc608\uce21 \ubc0f \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \uae30\uc220\uc758 \ubc1c\uc804\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc0dd\uc0b0 \uc8fc\uae30\ub97c \ub2e8\ucd95\uc2dc\ud0a4\ub294 \ud6a8\uacfc\ub97c \uac00\uc838\uc635\ub2c8\ub2e4. \uaddc\uc81c \uce21\uba74\uc5d0\uc11c\ub294 \ubbf8\uad6d FDA\uc758 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815(Breakthrough Designations)\uacfc \uc720\ub7fd EMA\uc758 PRIME \uc2b9\uc778 \ub4f1 \uaddc\uc81c \uc870\ud654 \ub178\ub825\uc774 \uad6d\uacbd \uac04 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \ub9c8\ucc30\uc744 \uc904\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \ud30c\ud2b8\ub108\uc2ed \uc911\uc2ec\uc758 \ube44\uc988\ub2c8\uc2a4 \ubaa8\ub378\uc740 \ub2e8\uc77c \uc81c\ud488\ubcf4\ub2e4\ub294 \ud50c\ub7ab\ud3fc \ucc28\ubcc4\ud654\uc5d0 \uc790\ubcf8\uc744 \uc9d1\uc911\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc9c0\ub9cc, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d \uac1c\ubc1c\uc790\ub4e4\uc774 \uc11c\uad6c\uad8c \ub300\ube44 99% \ub0ae\uc740 \ube44\uc6a9\uc73c\ub85c mRNA \ubc31\uc2e0\uc744 \uc81c\uacf5\ud558\uba70 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc138\ub97c \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804\ubc18\uc801\uc73c\ub85c mRNA \uc2dc\uc7a5\uc740 \uae30\uc220 \ud601\uc2e0\uacfc \uaddc\uc81c \uc9c0\uc6d0, \uadf8\ub9ac\uace0 \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \uc774\uc5b4\ub098\uac08 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc554 \ubc31\uc2e0 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc7ac\uc870\ud569 \ubc31\uc2e0, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f DNA \ubc31\uc2e0, mRNA\/\uc2e0\ud56d\uc6d0 \ub9de\ucda4\ud615 \ubc31\uc2e0, \uc804\uc138\ud3ec \ubc0f \uc218\uc9c0\uc0c1 \uc138\ud3ec \ubc31\uc2e0 \ub4f1 \ubaa8\ub4e0 \uc2b9\uc778\ub41c \uae30\uc220\uc744 \ud3ec\ud568\ud558\uc5ec \uc545\uc131 \uc138\ud3ec\uc5d0 \ub300\ud55c \uba74\uc5ed \ubc18\uc751\uc744 \uc790\uadf9\ud558\ub294 \uc608\ubc29 \ubc0f \uce58\ub8cc \ubc31\uc2e0\uc758 \ub204\uc801 \ub9e4\ucd9c\uc744 \uae30\uc900\uc73c\ub85c \uc815\uc758\ub429\ub2c8\ub2e4. \uc774\ub294 \ubcd1\uc6d0, \uacf5\uacf5 \uc608\ubc29\uc811\uc885 \ud504\ub85c\uadf8\ub7a8 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc5d0 \ud310\ub9e4\ub418\ub294 \uc644\uc81c\ud488, \ub77c\ubca8\ub9c1\ub41c \uc6a9\ub7c9\uc744 \ud3ec\ud568\ud558\uba70, \uc784\uc0c1 1\/2\uc0c1 \uc2dc\ud5d8 \uc911\uc778 \ud6c4\ubcf4 \ubb3c\uc9c8 \ubc0f \ub3d9\ubc18 \uc9c4\ub2e8 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c\ub294 \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc554 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 190\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub418\uba70, \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 10.14%\uc5d0 \ub2ec\ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 mRNA \uc81c\uc870 \ubc0f \ub300\uaddc\ubaa8 \ud658\uc790\uad70\uc5d0 \ud798\uc785\uc5b4 11.05%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae30\uc220\ubcc4\ub85c\ub294 mRNA\/\uc2e0\ud56d\uc6d0 \ud50c\ub7ab\ud3fc\uc774 \ube60\ub978 \ub9de\ucda4\ud654 \ubc0f \uac15\ub825\ud55c \uc784\uc0c1 \ud6a8\ub2a5 \uc2e0\ud638\uc5d0 \ub530\ub77c 10.96%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \ud655\uc7a5\ub418\ub294 \ubd80\ubb38\uc785\ub2c8\ub2e4. \uce58\ub8cc \ubc29\ubc95\ubcc4\ub85c\ub294 \uc608\ubc29 \ubc31\uc2e0\uc774 2025\ub144 \ub9e4\ucd9c\uc758 89.35%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \uc9c0\ubc30\uc801\uc774\uc9c0\ub9cc, \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc740 11.07%\uc758 \ub354 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804\ub2ec \uacbd\ub85c \uce21\uba74\uc5d0\uc11c\ub294 \uc804\uc774\uc131 \uc885\uc591\uc5d0 \ud544\uc218\uc801\uc778 \uc6b0\uc218\ud55c \uc804\uc2e0 \uba74\uc5ed \ud65c\uc131\ud654\ub97c \uc81c\uacf5\ud558\ub294 \uc815\ub9e5 \uc8fc\uc0ac \ubc29\uc2dd\uc774 \uc81c\ud615 \uac1c\uc120\uacfc \ud568\uaed8 10.88%\uc758 CAGR\ub85c \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc804 \uc138\uacc4\uc801\uc778 \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00, R&#038;D \ud22c\uc790 \ubc0f \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 \ud655\ub300, mRNA \ubc0f \uc2e0\ud56d\uc6d0 \ud50c\ub7ab\ud3fc\uc758 \ubc1c\uc804, AI \uae30\ubc18 \ud56d\uc6d0 \uc608\uce21\uc744 \ud1b5\ud55c \ube44\uc6a9 \uc808\uac10, \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \ud5c8\ube0c\uc758 \ub4f1\uc7a5, \uadf8\ub9ac\uace0 CPI(\uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c)\uc640\uc758 \ubcd1\uc6a9 \uc694\ubc95\uc744 \ud1b5\ud55c \uc784\uc0c1 \uc2dc\ud5d8 \uc704\ud5d8 \uac10\uc18c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \uc5c4\uaca9\ud55c \uaddc\uc81c \uc2b9\uc778 \uc808\ucc28 \ubc0f \ubcf5\uc7a1\uc131, \ub300\uccb4 \uba74\uc5ed \uce58\ub8cc\ubc95\uc758 \uac00\uc6a9\uc131, \uac1c\uc778 \ub9de\ucda4\ud615 \ubb3c\ub958\ub97c \uc704\ud55c \ucf5c\ub4dc\uccb4\uc778 \uc778\ud504\ub77c \ubd80\uc871, \uadf8\ub9ac\uace0 \uc2e0\ud56d\uc6d0 IP(\uc9c0\uc801\uc7ac\uc0b0\uad8c)\uc758 \uc9d1\uc911\uc73c\ub85c \uc778\ud55c \uc2e0\uaddc \uc9c4\uc785 \uc7a5\ubcbd \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd\uc5d0\uc11c\ub294 BioNTech\uc758 \uc81c\ud734\uc640 \uac19\uc774 AI \ubd84\uc11d, \uc81c\uc870 \ubc0f \uc784\uc0c1 \uc811\uadfc\uc131\uc5d0\uc11c \uac15\uc810\uc744 \uacb0\ud569\ud558\ub294 \ud30c\ud2b8\ub108\uc2ed \uae30\ubc18\uc758 \uc0dd\ud0dc\uacc4 \uad6c\ucd95 \uc804\ub7b5\uc774 \ub3c5\ub9bd\uc801\uc778 \uacbd\uc7c1\uc744 \ub118\uc5b4 \uc8fc\uc694 \ud2b8\ub80c\ub4dc\ub85c \uc790\ub9ac \uc7a1\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Merck &#038; Co., GlaxoSmithKline plc, Moderna Inc., Bristol Myers Squibb Co., AstraZeneca plc, F. Hoffmann-La Roche AG (Genentech), BioNTech SE \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \uc2dc\uc7a5 \ubd84\uc11d\uc744 \uc704\ud574 \uc5c4\uaca9\ud55c \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \ucc44\ud0dd\ud588\uc2b5\ub2c8\ub2e4. 1\ucc28 \uc5f0\uad6c(\uc885\uc591 \uc804\ubb38\uc758, \uc608\ubc29\uc811\uc885 \ud504\ub85c\uadf8\ub7a8 \uad00\ub9ac\uc790, \uc81c\uc870 \ucc45\uc784\uc790 \uc778\ud130\ubdf0)\uc640 2\ucc28 \uc5f0\uad6c(\ubbf8\uad6d CDC, \uc720\ub7fd \uc9c8\ubcd1\uc608\ubc29\ud1b5\uc81c\uc13c\ud130, \uc77c\ubcf8 PMDA \ub4f1 \uaddc\uc81c \uae30\uad00\uc758 \ucd9c\ud558 \ubc0f \uac00\uaca9 \ub370\uc774\ud130, GLOBOCAN, WHO\uc758 \ubc1c\ubcd1\ub960 \ubc0f \uc811\uc885\ub960 \ud1b5\uacc4, \uae30\uc5c5 \uc7ac\ubb34 \ubcf4\uace0\uc11c \ub4f1)\ub97c \ubcd1\ud589\ud588\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21\uc740 \uad6d\uac00\ubcc4 \uc554 \ubc1c\ubcd1\ub960\uc744 \ubc31\uc2e0 \uc811\uc885 \ub300\uc0c1 \uc778\uad6c\ub85c \uc804\ud658\ud558\uace0 \uc5f0\ub839\ubcc4 \uc811\uc885\ub960 \ubc0f \uac00\uc911 \ud3c9\uade0 \ud310\ub9e4 \uac00\uaca9\uc744 \uc801\uc6a9\ud558\ub294 \ud558\ud5a5\uc2dd \ubaa8\ub378\uacfc \uacf5\uae09\uc5c5\uccb4 \ud310\ub9e4\ub7c9 \ub370\uc774\ud130\ub97c \ud65c\uc6a9\ud55c \uc0c1\ud5a5\uc2dd \uac80\uc99d\uc744 \ud1b5\ud574 \uc774\ub8e8\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \uc0c1\uc5c5\ud654\ub41c \uc81c\ud615\uc5d0 \ucd08\uc810\uc744 \ub9de\ucdb0 \ud30c\uc774\ud504\ub77c\uc778 \uc81c\ud488\uc758 \uc608\uc0c1 \ub9e4\ucd9c\uc744 \uacfc\ub3c4\ud558\uac8c \ud3ec\ud568\ud558\uc9c0 \uc54a\uace0 \ud604\uc2e4\uc801\uc778 \ucd9c\uc2dc \uc18d\ub3c4\ub97c \ubc18\uc601\ud558\uc5ec \uc2e0\ub8b0\uc131 \uc788\ub294 \uae30\uc900\uc120\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc554 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 \uc9c0\uc18d\uc801\uc778 \uae30\uc220 \ud601\uc2e0\uacfc \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \ub192\uc740 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c0\uace0 \uc788\uc73c\uba70, \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \ud574\uacb0\ud558\uace0 \ubbf8\ub798 \uc758\ub8cc \ud658\uacbd\uc744 \ubcc0\ud654\uc2dc\ud0ac \uc911\uc694\ud55c \uae30\ud68c\ub97c \uc81c\uacf5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32430","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/32430"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=32430"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/32430\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=32430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=32430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=32430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}